Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case-control study

被引:15
|
作者
Meschiari, Marianna [1 ]
Kaleci, Shaniko [2 ]
Orlando, Gabriella [1 ]
Selmi, Silvia [1 ]
Santoro, Antonella [1 ]
Bacca, Erica [1 ]
Menozzi, Marianna [1 ]
Franceschini, Erica [1 ]
Puzzolante, Cinzia [1 ]
Bedini, Andrea [1 ]
Sarti, Mario [3 ]
Venturelli, Claudia [3 ]
Vecchi, Elena [4 ]
Mussini, Cristina [1 ]
机构
[1] Univ Modena & Reggio Emilia, Azienda Osped Univ, Dept Infect Dis, Via Pozzo 71, I-41122 Modena, Italy
[2] Univ Modena & Reggio Emilia, Clin & Expt Med, Modena, Italy
[3] Univ Modena & Reggio Emilia, Clin Microbiol Lab, Modena, Italy
[4] Azienda Osped Univ, Hosp Hyg & Infect Control, Modena, Italy
关键词
Carbapenem-resistant Acinetobacter baumannii; Rectal colonization; Surveillance; Risk factors; Endemic hospital;
D O I
10.1186/s13756-021-00919-6
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background During the last decade carbapenem-resistant Acinetobacter baumannii (CRAB) became hyper-endemic in hospitals due to difficult to control spreading. Our aim is to identify risk factors for nosocomial rectal CRAB colonization in an endemic hospital. Methods A retrospective matched case-control study (ratio 1:2) with a prospective inclusion of cases and concurrent selection of controls was conducted from January 2017 to December 2018 in a tertiary-care hospital. Universal active surveillance for CRAB was implemented. Univariate and multivariate logistic regression was carried out using a stepwise selection method to compare prognostic factors between cases and controls. A sub-analysis was carried out according to the type of department. Results Forty-five cases with nosocomial rectal CRAB colonization and 90 controls were included. One hundred and two (75%) patients were hospitalized in medical departments. At multivariable analysis significant risk factors associated with CRAB colonization were: use of permanent devices (OR 10.15, 95% CI 2.27-45.39; P = 0.002), mechanical ventilation (OR 40.01, 95% CI 4.05-395.1; P = 0.002), urinary catheters (OR 4.9, 95% CI 1.52-16.19; P = 0.008), McCabe score (OR 5.45, 95% CI 1.87-15.89; P = 0.002), length of stay (OR 1.03, 95% CI 1.01-1.05; P = 0.002), carbapenem use (OR 5.39, 95% CI 1.14-25.44; P = 0.033). The sub-analysis showed that patients admitted to different departments had different risk factors. In geriatric department a fatal disease and a longer hospital stay represented significant risk factors both in univariate and multivariate analysis, while in internal medicine department the use of permanent devices, current antibiotic therapy and antibiotic polytherapy represented significant risk factors for CRAB at the univariate analysis, also confirmed in multivariate analysis. Conclusions Our data suggest that active surveillance for rectal CRAB colonization should be addressed to patients with an unfavourable prognosis, longer hospitalizations and carriers of multiple devices. To counter CRAB spreading in endemic settings, clinicians must limit the use of carbapenems, and reinforce interventions aimed at proper use of devices.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Risk factors for nosocomial rectal colonisation with carbapenem-resistant Gram-negative bacilli in children with haematological malignancies: a case-control study
    Fang, Chao
    Zhou, Zheng
    Zhou, Mingming
    Li, Jianping
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2023, 22 (01)
  • [22] Risk factors for nosocomial rectal colonisation with carbapenem-resistant Gram-negative bacilli in children with haematological malignancies: a case-control study
    Chao Fang
    Zheng Zhou
    Mingming Zhou
    Jianping Li
    Annals of Clinical Microbiology and Antimicrobials, 22
  • [23] Risk factors for Carbapenem-resistant Enterobacterales infections: A case-control study
    Mbele, Sibongakonke
    Vasaikar, Sandeep D.
    SOUTH AFRICAN FAMILY PRACTICE, 2025, 67 (01)
  • [24] Molecular Mechanisms Associated with Nosocomial Carbapenem-resistant Acinetobacter baumannii in Mexico
    Dolores Alcantar-Curiel, Maria
    Francisco Garcia-Torres, Luis
    Ines Gonzalez-Chavez, Maria
    Morfin-Otero, Rayo
    Gayosso-Vazquez, Catalina
    Dolores Jarillo-Quijada, Ma.
    Luis Fernandez-Vazquez, Jose
    Giono-Cerezo, Silvia
    Rodriguez-Noriega, Eduardo
    Ignacio Santos-Preciado, Jose
    ARCHIVES OF MEDICAL RESEARCH, 2014, 45 (07) : 553 - 560
  • [25] Molecular characterization of oxacillinases among carbapenem-resistant Acinetobacter baumannii nosocomial isolates in a Saudi hospital
    Elabd, Faten M.
    Al-Ayed, Mohamed S. Z.
    Asaad, Ahmed M.
    Alsareii, Saeed A.
    Qureshi, Mohamed A.
    Musa, Hassan A. -A.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2015, 8 (03) : 242 - 247
  • [26] Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates
    Roy, S.
    Viswanathan, R.
    Singh, A.
    Das, P.
    Basu, S.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2010, 29 (12) : 1495 - 1500
  • [27] Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates
    S. Roy
    R. Viswanathan
    A. Singh
    P. Das
    S. Basu
    European Journal of Clinical Microbiology & Infectious Diseases, 2010, 29 : 1495 - 1500
  • [28] Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
    Carmi Bartal
    Kenneth V. I. Rolston
    Lior Nesher
    Infectious Diseases and Therapy, 2022, 11 : 683 - 694
  • [29] Risk Factors and Outcomes of Carbapenem-resistant Acinetobacter baumannii Bacteremia in Neonatal Intensive Care Unit: A Case-case-control Study
    Thatrimontrichai, Anucha
    Apisarnthanarak, Anucha
    Chanvitan, Prasin
    Janjindamai, Waricha
    Dissaneevate, Supaporn
    Maneenil, Gunlawadee
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (02) : 140 - 145
  • [30] Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options
    Bartal, Carmi
    Rolston, Kenneth V., I
    Nesher, Lior
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (02) : 683 - 694